flu vaccine

Latest Headlines

Latest Headlines

Is Agenus on GSK's shopping list?

It's been a busy week or two for GlaxoSmithKline ($GSK)--the company has extended its agreement with Agenus ($AGEN), submitted two vaccines for approval and created a joint venture.

AstraZeneca's FluMist Quadrivalent to hit U.S. market

The FDA has approved AstraZeneca's ($AZN) nasal FluMist Quadrivalent flu vaccine for use in people ages 2 to 49. Made at AstraZeneca's MedImmune unit, FluMist Quadrivalent contains two...

GlaxoSmithKline funds Canadian flu vaccine studies

GlaxoSmithKline ($GSK) is supporting Canadian flu studies to the tune of $12 million. The money will go toward an additional three years of tracking the incidence and severity of flu across Canada in...

GSK steps in to back Canadian vaccine project

GlaxoSmithKline ($GSK) is stepping in to support a Canadian project that tracks the use and effectiveness of flu vaccines.

Norovirus gets it in the nose

Call it what you like--stomach flu, gastroenteritis, tummy bug, winter vomiting virus--norovirus infections are not fun, especially on a cruise ship, and are even worse in a hospital ward. In the...

Adult vaccinations stay low in U.S.

It's understandable that kids don't like getting shots, but you would think that the grown-ups know what's good for them. Not so, perhaps--a recent report from the national Centers for...

Universal flu vaccine might be a step closer

Did you get the flu last year? Unfortunately, that won't stop you getting it this year, or next year, or whenever bird flu or swine flu next strikes, because the virus mutates so rapidly. This...

Gen X largely shrugged off call for H1N1 shots

About 2 of every 3 American adults aged 36 to 39 tracked the frenzy of reports that erupted after the swine flu pandemic broke out and concluded that there was something there that was at least...

Flu season gets off to a sluggish start

Where is this year's flu outbreak? In the wake of the H1N1 drama of a couple of years back, the virus seems to be laying low in the U.S. this season. But don't let your guard down: Flu...

Flu vax tool aids strain identification, timing

As manufacturers and researchers toil on alternatives to the tried-and-true but time-consuming technique of egg-based production for the seasonal flu vaccine, University of Pittsburgh researchers are